Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: Results from a randomized controlled trial
Titel:
Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: Results from a randomized controlled trial
Auteur:
Stroup, T. Scott Byerly, Matthew J. Nasrallah, Henry A. Ray, Neepa Khan, Ahsan Y. Lamberti, J. Steven Glick, Ira D. Steinbook, Richard M. McEvoy, Joseph P. Hamer, Robert M.